September 24, 2024

Clobetasol Soon to be Available in the US

A new topical ophthalmic steroid for postoperative inflammation and pain is now available to US patients.

Conexiant

September 24, 2024

Reducing Ophthalmic Inpatient Surgery Cancellations

Factors that contribute to cancellations and delays need to be understood to reduce the number of patients who do not receive care as needed.

Conexiant

September 18, 2024

PACD Eyes: Haigis Formula Tops IOL Calculations

Haigis formula achieved 83.81% of eyes within ±0.50 D prediction error for PACD patients, outperforming five other IOL calculation formulas in this challenging population.

Conexiant

September 09, 2024

First Full Eye, Face Transplant Performed

In a surgical first, retinal cells showed light responsiveness up to 9.0 μv at 220 days after whole eye transplant, nearing the low end of normal (10-50 μv).

Conexiant

September 09, 2024

Vision Impairment Linked to Nearly One-Fifth of Dementia

Vision impairment, particularly contrast sensitivity deficits, may account for up to 19% of dementia cases in older US adults, suggesting a potential target for prevention strategies.

Conexiant

May 23, 2024

New 3D Printing Method for Intraocular Lenses

Discover how a new stereolithography-based 3D printing method is advancing the prototyping of intraocular lenses, enhancing design flexibility and biocompatibility.

Conexiant

August 16, 2024

Cataract Surgery: Eom Formula May Improve Outcomes

Using an amalgamation of existing formulas helps to leverage the strengths of each method for improved IOL power prediction accuracy with the Eom formula.

Conexiant

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant

June 26, 2024

Daily Multivitamin Use: No Mortality Benefit Found

"In contrast, we found that daily multivitamin use vs. nonuse was associated with 4% higher mortality risk."

Conexiant